Chunhui Xu and her team leveraged the ISS National Laboratory ® for cardiac cell research to accelerate the development of cell-based regenerative therapies that could one day reverse heart damage.

Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance ...

Mar. 18, 2025 — Lifestyle and health factors that are linked with heart disease appear to have a greater impact on cardiovascular risk in women than ... Continued Medication Important for Heart ...

Our findings suggest deeper issues are contributing to the increase in the disease, particularly in Black women. Barriers to health care are critical. These include insurance gaps, transportation ...

A scientific technique that rapidly increases the body's production of anti-inflammatory cells promotes healing from heart ...

Compared with those who spent most of their time in a single room, people with heart failure with preserved ejection fraction (HFpEF) who were able to travel outside of their home without assistance ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor.

Heart failure is a pathological condition in which the heart is unable to pump enough blood to the rest of the body, because it is either unable to fill with a sufficient volume of blood or unable ...

The widowmaker heart attack lives up to its ominous name. Cardiologists break down the risks, symptoms, and heart-smart tips ...

The best negotiators don’t avoid failure but instead analyze and learn from it. Follow these five steps to turn a setback into a growth opportunity. Acknowledge—and accept—the failure.